The use of α1-adrenergic receptor antagonists in the prevention of adverse outcomes of COVID-19 infection in obese patients

The use of α1-adrenergic receptor antagonists in the prevention of adverse outcomes of COVID-19 infection in obese patients

Obesity is widely reported to be associated with a higher risk of the severity and worse clinical outcome of COVID-19. With the global prevalence of obesity, exploring the relationship between obesity and the severity of COVID-19 disease is of major clinical importance, thus requiring increased atte...

Full description

Bibliographic Details
Main Authors: Auda Fares, Resul Toprak, Dieter Borrman, Julius R Ivester
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2022-01-01
Series:Advances in Human Biology
Subjects:
alpha-blockers
alpha-1 adrenergic receptor antagonists
alpha-1 blockers covid-19
obesity
severe acute respiratory syndrome coronavirus-2
Online Access:http://www.aihbonline.com/article.asp?issn=2321-8568;year=2022;volume=12;issue=3;spage=329;epage=332;aulast=Fares

Internet

http://www.aihbonline.com/article.asp?issn=2321-8568;year=2022;volume=12;issue=3;spage=329;epage=332;aulast=Fares

Similar Items